Q2 2025 Holdings
Filed 2025-08-14 | 20 holdings | $7.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $1.3M | 167,350 | 16.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $1.2M | 22,500 | 15.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $770.0K | 120,119 | 9.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $689.9K | 52,500 | 8.8% |
| Evolus Inc(EOLS) | COM | 30052C107 | $552.6K | 60,000 | 7.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $532.1K | 119,294 | 6.8% |
| Merus N V | COM | N5749R100 | $473.4K | 9,000 | 6.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $452.2K | 40,000 | 5.8% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $277.6K | 40,353 | 3.5% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $260.6K | 6,000 | 3.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $236.5K | 2,500 | 3.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $204.8K | 40,000 | 2.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $172.7K | 4,000 | 2.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $165.2K | 5,000 | 2.1% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $149.6K | 9,356 | 1.9% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $142.0K | 4,000 | 1.8% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $103.4K | 4,000 | 1.3% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $76.3K | 155,720 | 1.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $65.9K | 1,000 | 0.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $44.9K | 9,000 | 0.6% |